Acetyl-L-carnitine restores synaptic transmission and enhances the inducibility of stable LTP after oxygen–glucose deprivation

Neuroscience

Volumn 332, Issue , 2016, Pages 203-211

  Kocsis, Kitti ^a,c   Frank, Rita ^a   Szabó, József ^a   Knapp, Levente ^a   Kis, Zsolt ^a   Farkas, Tamás ^a   Vécsei, László ^b,c   Toldi, József ^a,c  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

acetyl L carnitine; ischemia; long term potentiation; neuroprotection; oxygen glucose deprivation; PI3K Akt

Indexed keywords

ACETYLCARNITINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; CHROMONE DERIVATIVE; ENZYME INHIBITOR; GLUCOSE; MORPHOLINE DERIVATIVE; NEUROPROTECTIVE AGENT;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; HIPPOCAMPAL CA1 REGION; IN VITRO STUDY; LONG TERM POTENTIATION; MALE; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPTIC TRANSMISSION; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN ISCHEMIA; DEFICIENCY; DOSE RESPONSE; DRUG EFFECTS; EXCITATORY POSTSYNAPTIC POTENTIAL; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TISSUE CULTURE TECHNIQUE; WISTAR RAT;

ACETYLCARNITINE; ANIMALS; BRAIN ISCHEMIA; CA1 REGION, HIPPOCAMPAL; CHROMONES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; EXCITATORY POSTSYNAPTIC POTENTIALS; GLUCOSE; LONG-TERM POTENTIATION; MALE; MORPHOLINES; NEUROPROTECTIVE AGENTS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS, WISTAR; SIGNAL TRANSDUCTION; TISSUE CULTURE TECHNIQUES;

EID: 84978701751     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2016.06.046     Document Type: Article

References (30)

1. Abdul, H.M., Butterfield, D.A., Involvement of PI3K/PKG/ERK1/2 signaling pathways in cortical neurons to trigger protection by cotreatment of acetyl-L-carnitine and alpha-lipoic acid against HNE-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease. Free Radical Biol Med 42 (2007), 371–384.
2. Bieber, L.L., Carnitine. Annu Rev Biochem 57 (1988), 261–283.
3. Bremer, J., Carnitine–metabolism and functions. Physiol Rev 63 (1983), 1420–1480.
4. Brunet, A., Datta, S.R., Greenberg, M.E., Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr Opin Neurobiol 11 (2001), 297–305.
5. Burlina, A.P., Sershen, H., Debler, E.A., Lajtha, A., Uptake of acetyl-L-carnitine in the brain. Neurochem Res 14 (1989), 489–493.
6. Di Cesare Mannelli, L., Ghelardini, C., Calvani, M., Nicolai, R., Mosconi, L., Toscano, A., Pacini, A., Bartolini, A., Neuroprotective effects of acetyl-L-carnitine on neuropathic pain and apoptosis: a role for the nicotinic receptor. J Neurosci Res 87 (2009), 200–207.
7. Di Cesare Mannelli, L., Ghelardini, C., Toscano, A., Pacini, A., Bartolini, A., The neuropathy-protective agent acetyl-L-carnitine activates protein kinase C-gamma and MAPKs in a rat model of neuropathic pain. Neuroscience 165 (2010), 1345–1352.
8. Fiskum, G., Mechanisms of neuronal death and neuroprotection. J Neurosurg Anesthesiol 16 (2004), 108–110.
9. Foreman, P.J., Perez-Polo, J.R., Angelucci, L., Ramacci, M.T., Taglialatela, G., Effects of acetyl-L-carnitine treatment and stress exposure on the nerve growth factor receptor (p75NGFR) mRNA level in the central nervous system of aged rats. Prog Neuropsychopharmacol Biol Psychiatry 19 (1995), 117–133.
10. Ho, V.M., Lee, J.A., Martin, K.C., The cell biology of synaptic plasticity. Science 334 (2011), 623–628.
11. Horwood, J.M., Dufour, F., Laroche, S., Davis, S., Signalling mechanisms mediated by the phosphoinositide 3-kinase/Akt cascade in synaptic plasticity and memory in the rat. Eur J Neurosci 23 (2006), 3375–3384.
12. Jones, L.L., McDonald, D.A., Borum, P.R., Acylcarnitines: role in brain. Prog Lipid Res 49 (2010), 61–75.
13. Kirino, T., Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 239 (1982), 57–69.
14. Kocsis, K., Knapp, L., Gellert, L., Olah, G., Kis, Z., Takakuwa, H., Iwamori, N., Ono, E., Toldi, J., Farkas, T., Acetyl-L-carnitine normalizes the impaired long-term potentiation and spine density in a rat model of global ischemia. Neuroscience 269 (2014), 265–272.
15. Kocsis, K., Knapp, L., Meszaros, J., Kis, Z., Farkas, T., Vecsei, L., Toldi, J., Acetyl-L-carnitine and oxaloacetate in post-treatment against LTP impairment in a rat ischemia model. An in vitro electrophysiological study. J Neural Transm 122 (2015), 867–872.
16. Malaguarnera, M., Carnitine derivatives: clinical usefulness. Curr Opin Gastroenterol 28 (2012), 166–176.
17. Molz, S., Olescowicz, G., Kraus, J.R., Ludka, F.K., Tasca, C.I., Purine receptors are required for DHA-mediated neuroprotection against oxygen and glucose deprivation in hippocampal slices. Purinergic Signalling 11 (2015), 117–126.
18. Nistico, R., Piccirilli, S., Cucchiaroni, M.L., Armogida, M., Guatteo, E., Giampa, C., Fusco, F.R., Bernardi, G., Nistico, G., Mercuri, N.B., Neuroprotective effect of hydrogen peroxide on an in vitro model of brain ischaemia. Br J Pharmacol 153 (2008), 1022–1029.
19. Pettegrew, J.W., Levine, J., McClure, R.J., Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression. Mol Psychiatry 5 (2000), 616–632.
20. Picconi, B., Barone, I., Pisani, A., Nicolai, R., Benatti, P., Bernardi, G., Calvani, M., Calabresi, P., Acetyl-L-carnitine protects striatal neurons against in vitro ischemia: the role of endogenous acetylcholine. Neuropharmacology 50 (2006), 917–923.
21. Pulsinelli, W.A., Brierley, J.B., Plum, F., Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol 11 (1982), 491–498.
22. Rapoport, S.I., In vivo fatty acid incorporation into brain phospholipids in relation to signal transduction and membrane remodeling. Neurochem Res 24 (1999), 1403–1415.
23. Ronaldson, P.T., Davis, T.P., Targeted drug delivery to treat pain and cerebral hypoxia. Pharmacol Rev 65 (2013), 291–314.
24. Shu, Y., Zhang, H., Kang, T., Zhang, J.J., Yang, Y., Liu, H., Zhang, L., PI3K/Akt signal pathway involved in the cognitive impairment caused by chronic cerebral hypoperfusion in rats. PLoS One, 8, 2013, e81901.
25. Shug, A.L., Schmidt, M.J., Golden, G.T., Fariello, R.G., The distribution and role of carnitine in the mammalian brain. Life Sci 31 (1982), 2869–2874.
26. Ten, V.S., Starkov, A., Hypoxic–ischemic injury in the developing brain: the role of reactive oxygen species originating in mitochondria. Neurol Res Int, 2012, 2012, 542976.
27. Thompson, B.J., Ronaldson, P.T., Drug delivery to the ischemic brain. Adv Pharmacol 71 (2014), 165–202.
28. Xu, S., Waddell, J., Zhu, W., Shi, D., Marshall, A.D., McKenna, M.C., Gullapalli, R.P., In vivo longitudinal proton magnetic resonance spectroscopy on neonatal hypoxic–ischemic rat brain injury: neuroprotective effects of acetyl-L-carnitine. Magn Reson Med 74 (2015), 1530–1542.
29. Zanelli, S.A., Solenski, N.J., Rosenthal, R.E., Fiskum, G., Mechanisms of ischemic neuroprotection by acetyl-L-carnitine. Ann NY Acad Sci 1053 (2005), 153–161.
30. Zhou, P., Chen, Z., Zhao, N., Liu, D., Guo, Z.Y., Tan, L., Hu, J., Wang, Q., Wang, J.Z., Zhu, L.Q., Acetyl-L-carnitine attenuates homocysteine-induced Alzheimer-like histopathological and behavioral abnormalities. Rejuvenation Res 14 (2011), 669–679.